Stephanie Van de Ven

Publications

• Optical imaging with her2-targeted affibody molecules can monitor hsp90 treatment response in a breast cancer xenograft mouse model. van de Ven SM, Elias SG, Chan CT, Miao Z, Cheng Z, De A, Gambhir SS. Clin Cancer Res. 2012; 18 (4): 1073-81
• Molecular imaging using light-absorbing imaging agents and a clinical optical breast imaging system--a phantom study. van de Ven SM, Mincu N, Brunette J, Ma G, Khayat M, Ikeda DM, Gambhir SS. Mol Imaging Biol. 2011; 13 (2): 232-8
• Optical mammography combined with fluorescence imaging: lesion detection using scatterplots. Leproux A, van der Voort M, van der Mark MB, Harbers R, van de Ven SM, van Leeuwen TG. Biomed Opt Express. 2011; 2 (4): 1007-20
• A novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients. van de Ven S, Wiethoff A, Nielsen T, Brendel B, van der Voort M, Nachabe R, Van der Mark M, Van Beek M, Bakker L, Fels L, Elias S, Luijten P, Mali W. Mol Imaging Biol. 2010; 12 (3): 343-8
• Computer-aided detection (CAD) for breast MRI: evaluation of efficacy at 3.0 T. Meeuwis C, van de Ven SM, Stapper G, Fernandez Gallardo AM, van den Bosch MA, Mali WP, Veldhuis WB. Eur Radiol. 2010; 20 (3): 522-8
• Freehand MRI-guided preoperative needle localization of breast lesions after MRI-guided vacuum-assisted core needle biopsy without marker placement. van de Ven SM, Lin MC, Daniel BL, Sareen P, Lipson JA, Pal S, Dirbas FM, Ikeda DM. J Magn Reson Imaging. 2010; 32 (1): 101-9